Arcellx, Inc.

Historical 13F Holders

Symbol
ACLX
CUSIP
03940C100
All holders as of
Q2 2026
Type
Equity
Class
COMMON STOCK
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03940C100 since 12/18/2024, largest first.

Filer % of Class Filed
Gilead Sciences, Inc. 13D/A 100.0% 4/28/2026
Event 4/28/2026
BlackRock, Inc. 13G/A 6.4% 4/17/2025
Event 3/31/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (9)
T. Rowe Price Investment Management, Inc. 13G/A 4.5% 3/6/2026
Event 2/28/2026
Perceptive Advisors LLC 13G/A
4.5% 8/14/2025
Event 6/30/2025
RA Capital Management, L.P. 13G/A
2.2% 2/17/2026
Event 12/31/2025
FMR LLC 13G/A
0.5% 3/6/2026
Event 2/27/2026
Rami Elghandour 13D/A 0% 4/28/2026
Event 4/28/2026
New Enterprise Associates 15, L.P. 13D/A
0% 4/30/2026
Event 4/28/2026
Paradigm Biocapital Advisors LP 13G/A
0% 8/14/2026
Event 6/30/2026
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026
Vestal Point Capital, LP 13G/A
0% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q2 2 30.0 k $3.43M
2026 Q1 244 57.0 M $6.52B
2025 Q4 221 72.3 M $4.71B
2025 Q3 212 63.1 M $5.18B
2025 Q2 207 61.4 M $4.01B
2025 Q1 206 61.6 M $4.04B
2024 Q4 216 59.2 M $4.54B
2024 Q3 189 49.5 M $4.13B
2024 Q2 169 50.2 M $2.77B
2024 Q1 184 47.0 M $3.27B
2023 Q4 159 46.7 M $2.59B
2023 Q3 137 47.6 M $1.71B
2023 Q2 140 48.1 M $1.52B
2023 Q1 120 45.6 M $1.40B
2022 Q4 127 41.9 M $1.30B
2022 Q3 75 41.7 M $782M
2022 Q2 69 34.9 M $622M
2022 Q1 50 26.9 M $358M